DCM
RDY icon

DGS Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

DGS Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$733K Sell
52,937
-1,878
-3% -$26.1K 0.12% 167
2025
Q4 		$770K Sell
54,815
-7,487
-12% -$105K 0.13% 146
2025
Q3 		$871K Buy
62,302
+3,808
+7% +$54.8K 0.16% 125
2025
Q2 		$879K Buy
58,494
+105
+0.2% +$1.5K 0.18% 109
2025
Q1 		$770K Sell
58,389
-16,604
-22% -$229K 0.2% 105
2024
Q4 		$1.18M Buy
74,993
+15,308
+26% +$230K 0.3% 56
2024
Q3 		$948K Buy
59,685
+1,810
+3% +$29.1K 0.26% 75
2024
Q2 		$882K Buy
57,875
+8,265
+17% +$118K 0.25% 74
2024
Q1 		$728K Buy
49,610
+6,530
+15% +$95.3K 0.21% 91
2023
Q4 		$600K Buy
43,080
+4,590
+12% +$61.4K 0.23% 85
2023
Q3 		$515K Buy
38,490
+3,555
+10% +$48.1K 0.25% 91
2023
Q2 		$441K Buy
34,935
+1,075
+3% +$12.5K 0.22% 107
2023
Q1 		$386K Sell
33,860
-50
-0.1% -$540 0.21% 104
2022
Q4 		$351K Buy
33,910
+1,910
+6% +$20.6K 0.23% 110
2022
Q3 		$335K Buy
32,000
+1,640
+5% +$17.5K 0.22% 102
2022
Q2 		$336K Buy
30,360
+8,680
+40% +$94.4K 0.27% 88
2022
Q1 		$242K Buy
21,680
+3,665
+20% +$41.6K 0.15% 152
2021
Q4 		$236K Buy
+18,015
New +$227K 0.15% 132

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

DGS Capital Management's RDY Position: Q1 2026 in Review

DGS Capital Management reduced its Dr. Reddy's Laboratories (RDY) stake by 3.4% in Q1 2026, selling an estimated $26.1K and leaving 52,937 shares worth $733K. The position accounts for 0.12% of the portfolio, ranked #167.

DGS Capital Management first reported a position in RDY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.18M in Q4 2024. 249 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • DGS Capital Management held 52,937 shares of Dr. Reddy's Laboratories worth $733K as of Q1 2026.
  • DGS Capital Management sold 1,878 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $26.1K.
  • Dr. Reddy's Laboratories made up 0.12% of DGS Capital Management's portfolio in Q1 2026, its #167 holding.
  • DGS Capital Management first reported a position in Dr. Reddy's Laboratories in Q4 2021 and has held it in 18 quarters since.
  • DGS Capital Management's Dr. Reddy's Laboratories position peaked at $1.18M in Q4 2024.
  • 249 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on DGS Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.